« Federal study of Morgellons yields no answers – CBS News | Home | Lance introduces bill to streamline regulatory framework of treatments for … – MyCentralJersey.com »
Analysis Of Noteworthy Institutional 5% Ownership Filings For Wednesday And … – Seeking Alpha
By | January 26, 2012
->
|
Analysis Of Noteworthy Institutional 5% Ownership Filings For Wednesday And …
Seeking Alpha … of a collaboration with Intrexon for Synthetic DNA-based therapy for PAH, and then positive clinical study results for its oral zinc compound in ALS, announced by its collaborator, the PNA Center for Neurological Research, in late-November. |
Topics: Uncategorized | No Comments »
